Human immunodeficiency virus type 1 and other viral co-infections among young heterosexual men and women in Argentina

American Journal of Tropical Medicine and Hygiene

Volumn 71, Issue 2, 2004, Pages 153-159

  Pando, María De Los Angeles ^a   Biglione, Mirna M ^a   Toscano, Mauro Fernández ^b   Rey, Jorge A ^b   Russell, Kevin L ^c   Negrete, Monica ^d   Gianni, Silvia ^a   Martinez Peralta, Liliana ^a   Salomón, Horacio ^a   Sosa Estani, Sergio ^e   Montano, Silvia M ^d   Olson, James G ^d   Sanchez, José L ^f   Carr, Jean K ^f   Ávila, Maria M ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^c NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^d California   (Peru)

^e Administracion Nacional de Laboratorios E Institutos de Salud Dr Carlos G Malbran   (Argentina)

^f HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARGENTINA; ARTICLE; CONDOM; EDUCATION; FEMALE; GEOGRAPHIC DISTRIBUTION; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; QUESTIONNAIRE; RISK FACTOR; SEX RATIO; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; SEXUAL TRANSMISSION; VIRUS DIAGNOSIS; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; ARGENTINA; CROSS-SECTIONAL STUDIES; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HETEROSEXUALITY; HIV INFECTIONS; HIV-1; HTLV-I INFECTIONS; HTLV-II INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES;

HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; RNA VIRUSES;

EID: 4243198220     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Memon MI, Memon MA, 2002. Hepatitis C: an epidemiological review. J Viral Hepat 9: 84-100.
2. Stroffolini T, Lorenzoni U, Menniti-Ippolito F, Infantolino D, Chiaramonte M, 2001. Hepatitis C virus infection in spouses: sexual transmission or common exposure to the same risk factors? Am J Gastroenterol 96: 3138-3141.
3. Lamden KH, Kennedy N, Beeching NJ, Lowe D, Morrison CL, Mallinson H, Mutton KJ, Syed Q, 1998. Hepatitis B and hepatitis C virus infections: risk factors among drug users in Northwest England. J Infec 37: 260-269.
4. Bell J, Batey RG, Farrell GC, Crewe EB, Cunningham AL, Byth K, 1990. Hepatitis C virus in intravenous drug users. Med J Aust 153: 274-276.
5. Kane M, 1995. Global programme for control of hepatitis B infection. Vaccine 13 (Suppl 1): S47-S49.
6. Margolis HS, Alter MJ, Hadler SC, 1991. Hepatitis B: evolving epidemiology and implications for control. Semin Liver Dis 11: 84-92.
7. Alter HJ, Purcell RH, Gerin JL, Gerin JL, London WT, Kaplan PM, McAuliffe VJ, Wagner J, Holland PV, 1977. Transmission of hepatitis B to chimpanzees by hepatitis B surface antigen-positive saliva and semen. Infect Immun 16: 928-933.
8. Mueller N, 1991. The epidemiology of HTLV-I infection. Cancer Causes Control 2: 37-52.
9. Lairmore MD, Jacobson S, Gracia F, De BK, Castilla L, Larreategui M, Roberto BD, Levine PH, Blattner WA, Kaplan JE, 1990. Isolation of human T-cell lymphotropic virus type 2 from Guaymi Indians in Panama. Proc Natl Acad Sci USA 87: 8840-8844.
10. Lee H, Swasnson P, Shorty VS, Zack JA, Rosenblatt JD, Chen ISY, 1989. High rate of HTLV-II infection in seropositive IV drug abusers in New Orleans. Science 244: 471-475.
11. Khabbaz RF, Onorato IM, Cannon RO, Hartley TM, Roberts B, Hosein B, Kaplan JE, 1992. Seroprevalence of HTLV-I and HTLV-II among intravenous drug users and persons in clinics for sexually transmitted diseases. N Engl J Med 326: 375-380.
12. Dipierri JE, Tajima K, Cartier Robirosa L, Sonoda S, 1999. A seroepidemiological survey of HTLV-I/II carriers in the Puna Jujeña. Medicina (B Aires) 59: 717-720.
13. Biglione M, Pizarro M, Martínez Peralta L, Libonatti O, Avila M, 1999. High Prevalence of HTLV-I Infection in Argentinian Blood Donors. A new HTLV-I Endemic Area? J Acquir Immune Defic Syndr Hum Retrovirol 20: 101-102.
14. Bouzas MB, Zapiola I, Quiruelas S, Gorvein D, Panzita A, Rey J, Carnese FP, Corral R, Perez C, Zala C, 1994. HTLV type I and HTLV type II infection among Indians and natives from Argentina. AIDS Res Hum Retroviruses 10: 1567-1571.
15. Ferrer JF, Del Pino N, Esteban E, Sherman MP, Dube S, Dube D, Basombrio MA, Pimentel E, Segovia A, Quiruelas S, Poiesz BJ, 1993. High rate of infection with the human T-cell leukemia retrovirus type II in four Indian populations of Argentina. Virology 197: 576-584.
16. Biglione M, Gessain A, Quiruelas S, Fay O, Taborda MA, Fernández E, Lupo S, Panzita A, de The G, 1993. Endemic HTLV-II infection among Tobas and Matacos Amerindians from north Argentina (letter). J Acquir Immune Defic Syndr 6: 631-633.
17. Ávila MM, Pando MA, Carrion G, Martinez Peralta L, Salomon H, Gomez Carrillo M, Sanchez J, Maulen S, Hierholzer J, Marinello M, Negrete M, Russell KL, Carr JK, 2002. Two HIV-1 epidemics in Argentina: different genetic subtypes associated with different risk groups. J Acquir Immune Defic Syndr 29: 422-426.
18. Gutfraind Z, Blejer J, Saguier MC, Gomez Carretero ML, Pirola DA, Carreras Vescio LA, 1994. Seroprevalence of HTLV-I/HTLV-II in blood donors in Buenos Aires. Vox Sang 67: 408-409.
19. del Pino N, Martínez Peralta L, Pampuro S, Pimentel E, Libonatti O, 1994. HTLV-I/II seroprevalence and coinfection with other pathogens in blood donors in Buenos Aires (letter). J Acquir Immune Defic Syndr 7: 206-207.
20. Staples CT, Rimland D, Dudas D, 1999. Hepatitis C in the HIV (human immunodeficiency virus) Atlanta V.A. (Veterans Affairs Medical Center) Cohort Study (HAVACS): the effect of coinfection on survival. Clin Infect Dis 29: 150-154.
21. Soriano V, Rodriguez-Rosado R, Garcia-Samaniego J, 1999. Management of chronic hepatitis C in HIV-infected patients. AIDS 13: 539-546.
22. Bonacini M, Puoti M, 2000. Hepatitis C in patients with human immunodeficiency virus infection: diagnosis, natural history, meta analysis of sexual and vertical transmission, and therapeutic issues. Arch Intern Med 160: 3365-3373.
23. Sherman KE, O'Brien J, Gutierrez AG, Harrison S, Urdea M, Neuwald P, Wilber J, 1993. Quantitative evaluation of hepatitis C virus RNA in patients with concurrent human immunodeficiency virus infection. J Clin Microbiol 31: 2679-2682.
24. Bonacini M, Govindarajan S, Blatt LM, Schmid P, Conrad A, Lindsay K, 1999. Patients coinfected with human immunodeficiency virus demonstrate higher levels of hepatic HCV RNA. J Viral Hepat 6: 203-208.
25. Eyster ME, Alter HJ, Aledort LM, Quan S, Hatzakis A, Goedert JJ, 1991. Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Ann Intern Med 115: 764-768.
26. Global Illicit Drug Trends 2002, ODCCP, Studies on Drugs and Crime. United Nations Office for Drug Control and Crime Prevention. http://www.unodc.org, last access September 2003.
27. Roberts EA, Yeung L, 2002. Maternal-infant transmission of hepatitis C virus infection. Hepatology 36 (Suppl 1): S106-S113.
28. Bonacini M, Puoti M, 2000. Hepatitis C in patients with human immunodeficiency virus infection: diagnosis, natural history, meta-analysis of sexual and vertical transmission, and therapeutic issues. Arch Intern Med 160: 3365-3373.
29. Ranger-Rogez S, Alain S, Denis F, 2002. Virus des hépatites: transmission mére-enfant. Pathol Biol (Paris) 50: 568-575.
30. Hino S, Yamaguchi K, Katamine S, Sugiyama H, Amagasaki T, Kinoshita K, Yoshida Y, Doi H, Tsuji Y, Miyamoto T, 1985. Mother-to-child transmission of human T-cell leukemia virus type-I. Jpn J Cancer Res 76: 474-480.
31. Levine PH, Blattner WA, 1987. The epidemiology of diseases associated with HTLV-I and HTLV-II. Infect Dis Clin North Am 1: 501-510.
32. Centers for Disease Control and Prevention, 2001. National Hepatitis C Prevention Strategy: A Comprehensive Strategy for the Prevention and Control of Hepatitis C Virus Infection and Its Consequences. Atlanta: Ceners for Dusease Control and Prevention.
33. Centers for Disease Control and Prevention, 1998. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Morb Mortal Wkly Rep 47: 1-39.
34. Centers for Disease Control and Prevention, 1991. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination - recommendations of the lmmunization Practices Advisory Committee (ACIP). MMWR Morb Mortal Wkly Rep 40: 1-25.
35. Centers for Disease Control and Prevention, 1999. Notice to readers update: recommendations to prevent hepatitis B virus transmission - United States. MMWR Morb Mortal Wkly Rep 48: 33-34.